Perimenopause library · Symptoms

Mood during the transition: status matters more than one hormone draw

Updated 2026-08-24 · 2 min read

Mood changes in midlife get explained too quickly as “just hormones” or dismissed as “just stress.” The cohort evidence sits between those two slogans.

At the Pittsburgh SWAN site, Bromberger and colleagues (2011) followed 221 African American and Caucasian women who were 42–52 and premenopausal at entry, with yearly structured interviews. Odds of a major depressive episode were two to four times higher in peri- or early postmenopause than in premenopause. That association held after accounting for lifetime depression history, upsetting life events, psychotropic medicines, vasomotor symptoms, and measured estradiol, FSH, and testosterone.

A same-year SWAN review agreed with several other longitudinal studies that risk for high depressive symptoms and for depressive disorder is greater during the transition, and possibly after. Non-hormonal factors still matter: stressors, support, physical health, lifestyle.

The 2018 perimenopausal depression guidelines (Maki and colleagues) repeat the SWAN-type finding and add a caution: the elevated risk versus premenopause is clearest in people with prior major depression. Evidence for new-onset major depression in people with no midlife history is weaker and inconsistent. Hormone-level associations are inconsistent too. Being in the transition is a more robust signal than a single estradiol number.

ClearDay can help you notice sleep, mood, and flash patterns on the same timeline. It cannot tell you whether you have depression, whether hormones “caused” it, or what treatment you should start. If mood is heavy, persistent, or coupled with thoughts of self-harm, that is clinical care now — not an education article.

Read the product boundary